Clover Health Investments, Corp.
CLOV · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $496,650 | $477,620 | $462,331 | $336,963 |
| % Growth | 4% | 3.3% | 37.2% | – |
| Cost of Goods Sold | $423,473 | $377,992 | $353,442 | $243,044 |
| Gross Profit | $73,177 | $99,628 | $108,889 | $93,919 |
| % Margin | 14.7% | 20.9% | 23.6% | 27.9% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $97,148 | $109,793 | $109,697 | $115,023 |
| SG&A Expenses | $97,148 | $109,793 | $109,697 | $115,023 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $406 | $394 | $466 | $344 |
| Operating Expenses | $97,554 | $110,187 | $110,163 | $115,367 |
| Operating Income | -$24,377 | -$10,559 | -$1,274 | -$21,448 |
| % Margin | -4.9% | -2.2% | -0.3% | -6.4% |
| Other Income/Exp. Net | $0 | -$19 | $0 | -$33 |
| Pre-Tax Income | -$24,377 | -$10,578 | -$1,274 | -$21,481 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$24,377 | -$10,578 | -$1,274 | -$22,092 |
| % Margin | -4.9% | -2.2% | -0.3% | -6.6% |
| EPS | -0.048 | -0.021 | -0.003 | -0.045 |
| % Growth | -128.4% | -700% | 94.2% | – |
| EPS Diluted | -0.048 | -0.021 | -0.003 | -0.045 |
| Weighted Avg Shares Out | 512,744 | 508,894 | 497,056 | 491,871 |
| Weighted Avg Shares Out Dil | 512,744 | 508,894 | 497,056 | 491,871 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $406 | $394 | $466 | $344 |
| EBITDA | -$23,971 | -$10,184 | -$808 | -$21,137 |
| % Margin | -4.8% | -2.1% | -0.2% | -6.3% |